Videos

The House Energy and Commerce Subcommittee on Health held a hearing to examine ideas to modernize the Food and Drug Administration’s (FDA) regulation of over-the-counter drugs. Dr. Janet Woo…

Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also addressed senators' concerns over the lack of generic alternatives for c…

Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic drugs. She talked about progress being made on reduc…

Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a hearing on prescription drug cost increases. The CEOs …

Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and improving drug development. She outlined her concerns in the increasin…

Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified on the state of biomedical innovation and the sear…

The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration’s (FDA) drug development and approval process. Dr. Janet Woodcock, th…

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes available. At …

Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process was g…

Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process was g…

Food and Drug Administration (FDA) Commissioner Margaret Hamburg testified on the agency’s 2012 budget request.

A hearing was held on the circumstances surrounding the contamination of heparin imported from China. According to the FDA, 81 people have died after allergic reactions to the anticoagul…